140 related articles for article (PubMed ID: 7768199)
41. Pharmacology of the bipyridines: amrinone and milrinone.
Alousi AA; Johnson DC
Circulation; 1986 Mar; 73(3 Pt 2):III10-24. PubMed ID: 2417744
[TBL] [Abstract][Full Text] [Related]
42. Evoked changes in cardiovascular function in rats by infusion of levosimendan, OR-1896 [(R)-N-(4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)acetamide], OR-1855 [(R)-6-(4-aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one], dobutamine, and milrinone: comparative effects on peripheral resistance, cardiac output, dP/dt, pulse rate, and blood pressure.
Segreti JA; Marsh KC; Polakowski JS; Fryer RM
J Pharmacol Exp Ther; 2008 Apr; 325(1):331-40. PubMed ID: 18171907
[TBL] [Abstract][Full Text] [Related]
43. Hemodynamic and inotropic effects of milrinone after heart transplantation in the setting of recipient pulmonary hypertension.
Chen EP; Bittner HB; Davis RD; Van Trigt P
J Heart Lung Transplant; 1998 Jul; 17(7):669-78. PubMed ID: 9703231
[TBL] [Abstract][Full Text] [Related]
44. Mechanism of the positive inotropic effect of milrinone in cultured embryonic chick ventricular cells.
Olson EM; Kim D; Smith TW; Marsh JD
J Mol Cell Cardiol; 1987 Jan; 19(1):95-104. PubMed ID: 2435920
[TBL] [Abstract][Full Text] [Related]
45. Comparison of a conscious versus anesthetized canine model in response to milrinone, hydralazine and nitroprusside.
Lee KC; Canniff PC; Hamel DW; Clas DM
Methods Find Exp Clin Pharmacol; 1993; 15(6):377-85. PubMed ID: 8231457
[TBL] [Abstract][Full Text] [Related]
46. Cardiotonic and coronary vasodilator responses to milrinone, forskolin, and analog P87-7692 in the anesthetized dog.
Lebedinsky Y; Nordstrom ST; Aschoff SE; Kapples JF; O'Malley GJ; Kosley RW; Fielding S; Hubbard JW
J Cardiovasc Pharmacol; 1992 May; 19(5):779-89. PubMed ID: 1381777
[TBL] [Abstract][Full Text] [Related]
47. Milrinone improves intestinal villus blood flow during endotoxemia.
Schmidt W; Tinelli M; Secchi A; Gebhard MM; Martin E; Schmidt H
Can J Anaesth; 2000 Jul; 47(7):673-9. PubMed ID: 10930208
[TBL] [Abstract][Full Text] [Related]
48. Translational assessment of cardiac contractility by echocardiography in the telemetered rat.
Tang HM; Ju H; Zhao S; LaDuke C; Hahn S; Glick J; Carey C; Friedrichs GS
J Pharmacol Toxicol Methods; 2016; 77():24-32. PubMed ID: 26427954
[TBL] [Abstract][Full Text] [Related]
49. [Hemodynamic effects of milrinone in the treatment of cardiac insufficiency after heart surgery with extracorporeal circulation].
Lançon JP; Caillard B; Obadia JF; Pillet M; Leblanc-Beaufils C; Le Bloch Y
Arch Mal Coeur Vaiss; 1991 Nov; 84(11):1575-9. PubMed ID: 1763924
[TBL] [Abstract][Full Text] [Related]
50. Chronotropic and inotropic effects of milrinone and congeners: comparison with PDE III inhibition.
Dorigo P; Floreani M; Belluco P; Gaion RM; Carpenedo F
Acta Physiol Hung; 1990; 75 Suppl():85-6. PubMed ID: 2371910
[No Abstract] [Full Text] [Related]
51. Beneficial hemodynamic effects of milrinone and enalapril in conscious rats with healed myocardial infarction.
DeFelice A; Harris A; Frering R; Horan P
Eur J Pharmacol; 1989 Aug; 167(2):211-20. PubMed ID: 2556283
[TBL] [Abstract][Full Text] [Related]
52. Phosphodiesterase isozyme inhibition, activation of the cAMP system, and positive inotropy mediated by milrinone in isolated guinea pig cardiac muscle.
Silver PJ; Harris AL; Canniff PC; Lepore RE; Bentley RG; Hamel LT; Evans DB
J Cardiovasc Pharmacol; 1989 Apr; 13(4):530-40. PubMed ID: 2470989
[TBL] [Abstract][Full Text] [Related]
53. Short-term use of intravenous milrinone for heart failure.
Konstam MA; Cody RJ
Am J Cardiol; 1995 Apr; 75(12):822-6. PubMed ID: 7717288
[No Abstract] [Full Text] [Related]
54. Milrinone versus dobutamine: contribution of altered myocardial mechanics and augmented inotropic state to improved left ventricular performance.
Borow KM; Neumann A; Lang RM
Circulation; 1986 Mar; 73(3 Pt 2):III153-61. PubMed ID: 3943179
[TBL] [Abstract][Full Text] [Related]
55. Role of reflex sympathetic withdrawal in the hemodynamic response to an increased inotropic state in patients with severe heart failure.
Arnold JM; Ludmer PL; Wright RF; Ganz P; Braunwald E; Colucci WS
J Am Coll Cardiol; 1986 Aug; 8(2):413-8. PubMed ID: 3734263
[TBL] [Abstract][Full Text] [Related]
56. In-vivo effects of amrinone and milrinone on left ventricular dP/dt, intraventricular pressure and heart rate in pentobarbital-anesthetized guinea pigs.
Lin BB; Chen HL
Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):237-40. PubMed ID: 1811284
[TBL] [Abstract][Full Text] [Related]
57. Myocardial actions of milrinone: characterization of its mechanism of action.
Rapundalo ST; Grupp I; Grupp G; Abdul Matlib M; Solaro RJ; Schwartz A
Circulation; 1986 Mar; 73(3 Pt 2):III134-44. PubMed ID: 2417746
[TBL] [Abstract][Full Text] [Related]
58. Mechanisms of desensitization to a PDE inhibitor (milrinone) in conscious dogs with heart failure.
Sato N; Asai K; Okumura S; Takagi G; Shannon RP; Fujita-Yamaguchi Y; Ishikawa Y; Vatner SF; Vatner DE
Am J Physiol; 1999 May; 276(5):H1699-705. PubMed ID: 10330256
[TBL] [Abstract][Full Text] [Related]
59. Cardiovascular responses to experimental infra-renal aortic cross-clamping. Modulating effects of isoflurane, sodium nitroprusside and milrinone.
Seeman-Lodding H; Biber B; Martner J; Pontén J; Winsö O
Acta Anaesthesiol Scand; 1996 Apr; 40(4):408-15. PubMed ID: 8738683
[TBL] [Abstract][Full Text] [Related]
60. Effect of flosequinan on ischaemia-induced arrhythmias and on ventricular cyclic nucleotide content in the anaesthetized rat.
Jones RB; Frodsham G; Dickinson K; Foster GA
Br J Pharmacol; 1993 Apr; 108(4):1111-6. PubMed ID: 8097953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
